Hepatitis A virus-induced autoimmune hepatitis: A case-based review Jakub Janczura, Michał Brzdęk, Kinga Brzdęk, Piotr Lewitowicz, Nina Zbylut, Dorota Zarębska-Michaluk, Piotr M Stępień, Krystyna Dobrowolska World Journal of Hepatology.2026;[Epub] CrossRef
Hard-to-treat autoimmune hepatitis and primary biliary cholangitis: The dawn of a new era of pharmacological treatment Atsumasa Komori, Yuki Kugiyama Clinical and Molecular Hepatology.2025; 31(1): 90. CrossRef
Histopathology of Autoimmune Hepatitis: An Update Despoina Myoteri, Stratigoula Sakellariou, Dina G. Tiniakos Advances in Anatomic Pathology.2025; 32(6): 414. CrossRef
EASL Clinical Practice Guidelines on the management of autoimmune hepatitis George Dalekos, Nikolaos Gatselis, Joost P. Drenth, Michael Heneghan, Marianne Jørgensen, Ansgar W. Lohse, Maria Londoño, Luigi Muratori, Maria Papp, Marianne Samyn, Dina Tiniakos, Ana Lleo Journal of Hepatology.2025; 83(2): 453. CrossRef
Drug-Induced Autoimmune Hepatitis: Robust Causality Assessment Using Two Different Validated and Scoring Diagnostic Algorithms Rolf Teschke, Axel Eickhoff, Gaby Danan Diagnostics.2025; 15(13): 1588. CrossRef
Reply to: “Evaluation of the histological scoring systems of autoimmune hepatitis: A significant step towards the optimization of clinical diagnosis” Haeryoung Kim, Sook-Hyang Jeong Clinical and Molecular Hepatology.2024; 30(2): 291. CrossRef
A Case of Autoimmune Hepatitis Initially Manifesting as Hepatic Encephalopathy Shengmin Yang, Ning Zhang, Xiang Li, Yunlong Li, Liangrui Zhou, Yuchen Wei, Kanghao Zhou, Hui Pan, Lin Kang Cureus.2024;[Epub] CrossRef
Reply to correspondence on “Comparison of four histological scoring systems for autoimmune hepatitis to improve diagnostic sensitivity” Atsumasa Komori Clinical and Molecular Hepatology.2024; 30(4): 1035. CrossRef
Autoimmune liver diseases including autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC) are rare diseases. The aim of this review is to examine the epidemiology and clinical characteristics of AIH and PBC in South Korea. There were 4,085 patients registered as AIH in the Rare Intractable Disease Registry of Korea between 2009-2013, with a median age of 56 years and female-to male ratio of 6.4. The age-adjusted incidence and prevalence of AIH were 1.07/100,000/year and 4.82/100,000 persons, respectively. Among the patients, 1.1% underwent liver transplantation, and case fatality was 2.18%. Liver cirrhosis at diagnosis was accompanied in 23%; liver biopsy was performed in 75.2%, and prednisolone therapy or prednisolone and azathioprine combination therapy was done in 73% with a remission rate of 86%. There were 2,824 patients with PBC (≥20 years) registered in Korea between 2009-2013 with a median age of 57 years and female-to male ratio of 6.2. The age-adjusted incidence and prevalence of PBC were 0.86/100,000/year and 4.75/100,000 persons, respectively. Among the patients, 2.5% underwent liver transplantation, and case fatality was 2.2% with a 5-year transplantation-free survival of 95.4%. Ursodeoxycholic acid (UDCA) was prescribed in 90% of the patients with a UDCA inadequate response rate of 30%. In conclusion, AIH and PBC are rare but mostly treatable diseases if diagnosed in the early stages. However, scarce data, low awareness, delayed diagnosis and non-availability of 2nd line therapeutics are important issues to be solved. Therefore, governmental support for research and drug development and nationwide cooperative studies are warranted.
Citations
Citations to this article as recorded by
The Clinical Impact of Early Steroid Withdrawal on Diabetes Mellitus After Liver Transplantation: A Population-Based Cohort Study Haeseon Lee, YoungRok Choi, Hae Sun Suh Transplant International.2026;[Epub] CrossRef
Clinical Outcomes of Children With Autoimmune Hepatitis in Korea: A Nationwide Multicenter Study Jeong Eun Ahn, Jae Sung Ko, Jin Soo Moon, Shinjie Choi, Yeoun Joo Lee, Eun Joo Lee, Hong Koh, Ho Jung Choi, Seak Hee Oh, Kyung Mo Kim, Ki Soo Kang, Byung-Ho Choe, Seo-Hee Kim, Eun Sil Kim, Mi Jin Kim, Seon Young Kim, Kyung Jae Lee Journal of Korean Medical Science.2026;[Epub] CrossRef
Natural Alkaloids Against Liver Injury: Mechanistic Insights and Multi-Target Therapeutic Potential Yating Xiao, Zhirui Tian, Jie Cui, Xia Yang, Dong Wang, Yangyang Cai, Qian Wu, Yaxin Jin, Hua Chen, Kai Ji Biomolecules.2026; 16(6): 815. CrossRef
Clinical Characterization of Autoimmune Hepatic Involvement in Sjogren’s Disease: A Retrospective Cohort Study in Korea Youngjae Park, Jennifer Jooha Lee, Ji Hyeon Ju, Wan-Uk Kim, Sung-Hwan Park, Seung-Ki Kwok International Journal of Molecular Sciences.2025; 26(12): 5734. CrossRef
Autoimmune hepatitis: current concepts in epidemiology, diagnosis, and management Brian J. Wentworth, Kwang Il Seo Kosin Medical Journal.2025; 40(4): 249. CrossRef
Impact of primary biliary cholangitis severity on oral health status Anna R. Khokhlova, Natalia S. Robakidze, Karina L. Raykhelson, Margarita V. Klur Acta Universitatis Dentistriae et Chirurgiae Maxillofacialis.2025; 3(2): 67. CrossRef
Epidemiology of autoimmune liver disease in Korea: evidence from a nationwide real-world database Jihye Lim, Hwa Jung Kim Orphanet Journal of Rare Diseases.2024;[Epub] CrossRef
Registry of patients with autoimmune liver diseases in St. Petersburg: clinical and epidemiological data Igor G. Bakulin, Svetlana A. Burlakova, Ekaterina V. Skazyvaeva, Maria I. Skalinskaya HERALD of North-Western State Medical University named after I.I. Mechnikov.2024; 16(2): 61. CrossRef
Ionic Liquid 1-Octyl-3-Methylimidazolium (M8OI) Is Mono-Oxygenated by CYP3A4 and CYP3A5 in Adult Human Liver Alistair C. Leitch, Tarek M. Abdelghany, Alex Charlton, Martin Cooke, Matthew C. Wright Journal of Xenobiotics.2024; 14(3): 907. CrossRef
Treatment of Autoimmune Hepatitis Ja Kyung Kim The Korean Journal of Gastroenterology.2023; 81(2): 72. CrossRef
Diagnosis of Autoimmune Hepatitis Jeong Han Kim The Korean Journal of Gastroenterology.2023; 81(2): 66. CrossRef
Association of the etiology and peak level of markedly elevated aminotransferases with mortality: a multicenter study Ji Yoon Kwak, Hyun-gyu Kim, Ji Hee Han, Hankyu Jeon, Ra Ri Cha, Sang Soo Lee Hepatology Communications.2023;[Epub] CrossRef
KASL clinical practice guidelines for management of autoimmune hepatitis 2022
Clinical and Molecular Hepatology.2023; 29(3): 542. CrossRef
Effect on lipid profile and clinical outcomes of obeticholic acid for the treatment of primary biliary cholangitis and metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis Hyejung Jang, Nayoung Han, Christine E. Staatz, Jae-Hwan Kwak, In-hwan Baek Clinics and Research in Hepatology and Gastroenterology.2023; 47(10): 102227. CrossRef
Diagnostic Approach to Autoimmune Hepatitis Kiyoung Lim, Jung Gil Park The Korean Journal of Medicine.2022; 97(1): 33. CrossRef
Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China Zi-Xuan Shen, Dan-Dan Wu, Jie Xia, Xian-Bo Wang, Xin Zheng, Yan Huang, Bei-Ling Li, Zhong-Ji Meng, Yan-Hang Gao, Zhi-Ping Qian, Feng Liu, Xiao-Bo Lu, Jia Shang, Hua-Dong Yan, Yu-Bao Zheng, Wen-Yi Gu, Yan Zhang, Jian-Yi Wei, Wen-Ting Tan, Yi-Xin Hou, Qun Z World Journal of Gastroenterology.2022; 28(31): 4417. CrossRef
Contemporary Epidemiology of Primary Biliary Cholangitis Francesca Colapietro, Arianna Bertazzoni, Ana Lleo Clinics in Liver Disease.2022; 26(4): 555. CrossRef
Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events Joo Hyun Oh, Myung Ji Goh, Yewan Park, Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik Digestive Diseases and Sciences.2021; 66(8): 2816. CrossRef
Current understanding of primary biliary cholangitis Atsushi Tanaka Clinical and Molecular Hepatology.2021; 27(1): 1. CrossRef
Changing Trends in Liver Cirrhosis Etiology and Severity in Korea: the Increasing Impact of Alcohol Jae Hyun Yoon, Chung Hwan Jun, Jeong Han Kim, Eileen L. Yoon, Byung Seok Kim, Jeong Eun Song, Ki Tae Suk, Moon Young Kim, Seong Hee Kang Journal of Korean Medical Science.2021;[Epub] CrossRef
A Case of Autoimmune Hepatitis after Occupational Exposure to N,N-Dimethylformamide Boo-ok Jang, Gwang Hyeon Choi, Hee Yoon Jang, Soomin Ahn, Jae Kyun Choi, Siho Kim, Kyunghan Lee, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong Journal of Korean Medical Science.2020;[Epub] CrossRef
Long‐term clinical outcomes in patients with autoimmune hepatitis according to treatment response in Asian country Jonggi Choi, Gwang Hyeon Choi, Danbi Lee, Ju Hyun Shim, Young‐Suk Lim, Han Chu Lee, Young‐Hwa Chung, Yung‐Sang Lee, Kang Mo Kim Liver International.2019; 39(5): 985. CrossRef
Additional fibrate treatment in UDCA‐refractory PBC patients Sung Won Chung, Jeong‐Hoon Lee, Minseok Albert Kim, Galam Leem, Sun Woong Kim, Young Chang, Hyo Young Lee, Jun Sik Yoon, Jun Yong Park, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jung‐Hwan Yoon Liver International.2019; 39(9): 1776. CrossRef
Etiopathogenesis of autoimmune hepatitis Annarosa Floreani, Paula Restrepo-Jiménez, Maria Francesca Secchi, Sara De Martin, Patrick S.C. Leung, Edward Krawitt, Christopher L. Bowlus, M. Eric Gershwin, Juan-Manuel Anaya Journal of Autoimmunity.2018; 95: 133. CrossRef
Saera Jung, M.D., Han Chu Lee, M.D., Young Hwan Park, M.D., Sang Soo Lee, M.D.,
Hee Gon Song, M.D., Seung Il Pyo, M.D., Byung-Cheol Song, M.D.* ,
Young-Hwa Chung, M.D., Yung Sang Lee, M.D., and Dong Jin Suh, M.D.
Background/Aims There are no pathognomonic features of autoimmune hepatitis (AIH). Its diagnosis requires the exclusion of various other conditions. The aim of this study was to validate indirectly the International Autoimmune Hepatitis Group (IAHG) scoring system in diagnosing AIH. Methods: Twenty-six patients with Type 1 AIH and female patients with chronic hepatitis B (n=34), chronic hepatitis C (n=25), or toxic hepatitis (n=13) were evaluated according to 9 categories of pretreatment minimum required parameters proposed by IAHG. Aggregate scores of AIH to those of non-AIH groups, which were assessed before and after extracting the proportions of etiologic factors, were also compared and evaluated. Results: While aggregate scores of non-AIH groups, before extracting the proportions of etiologic factors, were 5.2±1.8, 5.6±1.1, and 7.4±1.2 in that order, those of AIH groups were 12.8±1.7. These were significantly higher than those of non-AIH groups (p<0.01). All patients in AIH groups and only 1 patient in a non-AIH group showed aggregate scores of more than 10. Aggregate scores after extracting the proportions of etiologic factors were more than 4 in all, except 2, patients. These should have been consistent with 10 if there were no etiologic factors in non-AIH groups. Conclusion: The IAHG scoring system might have a relatively excessive importance to the scores of categories excluding distinct etiologies from AIH. It might be difficult to differentiate AIH from chronic liver diseases of indistinct cause based on the IAHG scoring system.(Korean J Hepatol 2002;8:35-43)
First
Prev
